CD274 and cancer: Interestingly, ATXN3 appears to positively regulate PD-L1 expression at the transcriptional level, since real-time reverse transcription PCR analysis confirmed that Atxn3 targeting dramatically inhibited Cd274 mRNA expression in both LLC1 and B16 mouse cancer cells (Figure 1, J–M).